Catalyst Wire Dossier Catalyst Wire Dossier

DSUVIA

SUFENTANIL · AcelRx Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for DSUVIA, covering 2018-11-02 to 2025-12-22. Get the full timeline:

Most recent: FDA Approved: DSUVIA — Supplemental Application (AcelRx Pharmaceuticals, Inc.)

See pricing